TP53 and colorectal carcinoma: As shown in Fig. 3B, 33 enriched KEGG pathways (p < 0.05) are mainly involved in the cell cycle, p53 signaling pathway, PI3K-Akt signaling pathway, CRC, proteoglycans in cancer, pathways in cancer, and so on (Supplementary Table S4).